90 related articles for article (PubMed ID: 29530430)
1. Detection of GSK-3β activation index in pediatric chronic tonsillitis is an indicator for chronic recurrent inflammation.
Gao Y; Mi J; Chen F; Liao Z; Feng X; Lv M; He H; Cao Y; Yan Y; Zhu Z; Fan Y; Hong H
Am J Otolaryngol; 2018; 39(3):277-281. PubMed ID: 29530430
[TBL] [Abstract][Full Text] [Related]
2. GSK-3β activation index is a potential indicator for recurrent inflammation of chronic rhinosinusitis without nasal polyps.
Hong H; Chen F; Qiao Y; Yan Y; Zhang R; Zhu Z; Li H; Fan Y; Xu G
J Cell Mol Med; 2017 Dec; 21(12):3633-3640. PubMed ID: 28714566
[TBL] [Abstract][Full Text] [Related]
3. Production of proinflammatory mediators in activated microglia is synergistically regulated by Notch-1, glycogen synthase kinase (GSK-3β) and NF-κB/p65 signalling.
Cao Q; Karthikeyan A; Dheen ST; Kaur C; Ling EA
PLoS One; 2017; 12(10):e0186764. PubMed ID: 29049420
[TBL] [Abstract][Full Text] [Related]
4. Glycogen Synthase Kinase-3β (GSK-3β) and Nuclear Factor Kappa-B (NFKB) in Childhood Acute Lymphoblastic Leukemia.
Tovar CF; Zerón HM; Romero MD; Sánchez YV; Romero IT
Adv Clin Exp Med; 2016; 25(6):1139-1147. PubMed ID: 28028966
[TBL] [Abstract][Full Text] [Related]
5. Glycogen synthase kinase-3β inhibition induces nuclear factor-κB-mediated apoptosis in pediatric acute lymphocyte leukemia cells.
Hu Y; Gu X; Li R; Luo Q; Xu Y
J Exp Clin Cancer Res; 2010 Nov; 29(1):154. PubMed ID: 21110852
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of GSK-3beta mediates expression of MMP-9 through ERK1/2 activation and translocation of NF-kappaB in rat primary astrocyte.
Kim SD; Yang SI; Kim HC; Shin CY; Ko KH
Brain Res; 2007 Dec; 1186():12-20. PubMed ID: 17996850
[TBL] [Abstract][Full Text] [Related]
7. [Impact of glycogen synthase kinase-3β (GSK-3β) inhibitor on Wnt and NF-κB signal pathways in a rat model of diabetic nephropathy].
Zhou Y; Li L; Yu Y; Yang H; Yao H; Zhang Y; Zhang L; Deng C; Zhao L; Zhang Y; Song B
Zhonghua Bing Li Xue Za Zhi; 2015 Nov; 44(11):783-7. PubMed ID: 26888388
[TBL] [Abstract][Full Text] [Related]
8. Glycogen synthase kinase 3beta functions to specify gene-specific, NF-kappaB-dependent transcription.
Steinbrecher KA; Wilson W; Cogswell PC; Baldwin AS
Mol Cell Biol; 2005 Oct; 25(19):8444-55. PubMed ID: 16166627
[TBL] [Abstract][Full Text] [Related]
9. Glycogen synthase kinase-3 beta inhibitor suppresses Porphyromonas gingivalis lipopolysaccharide-induced CD40 expression by inhibiting nuclear factor-kappa B activation in mouse osteoblasts.
Die L; Yan P; Jun Jiang Z; Min Hua T; Cai W; Xing L
Mol Immunol; 2012 Aug; 52(1):38-49. PubMed ID: 22580404
[TBL] [Abstract][Full Text] [Related]
10. Ionizing radiation can induce GSK-3beta phosphorylation and NF-kappaB transcriptional transactivation in ATM-deficient fibroblasts.
Kwon O; Kim KA; He L; Kim SO; Kim MS; Cha EY; Yoon BD; Sok DE; Jung M; Ahn JS; Kim BY
Cell Signal; 2008 Apr; 20(4):602-12. PubMed ID: 18243662
[TBL] [Abstract][Full Text] [Related]
11. Indirubin-3'-monoxime prevents aberrant activation of GSK-3β/NF-κB and alleviates high fat-high fructose induced Aβ-aggregation, gliosis and apoptosis in mice brain.
Sathiya Priya C; Vidhya R; Kalpana K; Anuradha CV
Int Immunopharmacol; 2019 May; 70():396-407. PubMed ID: 30856390
[TBL] [Abstract][Full Text] [Related]
12. Atorvastatin Alleviates Experimental Diabetic Cardiomyopathy by Regulating the GSK-3β-PP2Ac-NF-κB Signaling Axis.
Ren XM; Zuo GF; Wu W; Luo J; Ye P; Chen SL; Hu ZY
PLoS One; 2016; 11(11):e0166740. PubMed ID: 27851811
[TBL] [Abstract][Full Text] [Related]
13. Revealing the effect of 6-gingerol, 6-shogaol and curcumin on mPGES-1, GSK-3β and β-catenin pathway in A549 cell line.
Eren D; Betul YM
Chem Biol Interact; 2016 Oct; 258():257-65. PubMed ID: 27645308
[TBL] [Abstract][Full Text] [Related]
14. GSK-3β controls NF-kappaB activity via IKKγ/NEMO.
Medunjanin S; Schleithoff L; Fiegehenn C; Weinert S; Zuschratter W; Braun-Dullaeus RC
Sci Rep; 2016 Dec; 6():38553. PubMed ID: 27929056
[TBL] [Abstract][Full Text] [Related]
15. Tissue kallikrein protects against pressure overload-induced cardiac hypertrophy through kinin B2 receptor and glycogen synthase kinase-3beta activation.
Li HJ; Yin H; Yao YY; Shen B; Bader M; Chao L; Chao J
Cardiovasc Res; 2007 Jan; 73(1):130-42. PubMed ID: 17137568
[TBL] [Abstract][Full Text] [Related]
16. Lithium exacerbates hepatic ischemia/reperfusion injury by inhibiting GSK-3β/NF-κB-mediated protective signaling in mice.
Xia Y; Rao J; Yao A; Zhang F; Li G; Wang X; Lu L
Eur J Pharmacol; 2012 Dec; 697(1-3):117-25. PubMed ID: 23051669
[TBL] [Abstract][Full Text] [Related]
17. Glycogen synthase kinase-3β is a crucial mediator of signal-induced RelB degradation.
Neumann M; Klar S; Wilisch-Neumann A; Hollenbach E; Kavuri S; Leverkus M; Kandolf R; Brunner-Weinzierl MC; Klingel K
Oncogene; 2011 May; 30(21):2485-92. PubMed ID: 21217772
[TBL] [Abstract][Full Text] [Related]
18. GABAB R/GSK-3β/NF-κB signaling pathway regulates the proliferation of colorectal cancer cells.
Shu Q; Liu J; Liu X; Zhao S; Li H; Tan Y; Xu J
Cancer Med; 2016 Jun; 5(6):1259-67. PubMed ID: 27060477
[TBL] [Abstract][Full Text] [Related]
19. RNA Interference Silencing of Glycogen Synthase Kinase 3β Inhibites Tau Phosphorylation in Mice with Alzheimer Disease.
Bian H; Bian W; Lin X; Ma Z; Chen W; Pu Y
Neurochem Res; 2016 Sep; 41(9):2470-80. PubMed ID: 27255602
[TBL] [Abstract][Full Text] [Related]
20. GSK-3β inhibition attenuates CLP-induced liver injury by reducing inflammation and hepatic cell apoptosis.
Zhang H; Wang W; Fang H; Yang Y; Li X; He J; Jiang X; Wang W; Liu S; Hu J; Liu A; Dahmen U; Dirsch O
Mediators Inflamm; 2014; 2014():629507. PubMed ID: 25525303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]